RAD51 and cancer: Since homologous recombination is an essential DNA repair pathway to preserve genomic stability, its inhibition, namely, by targeting ATM, ATR, CHK1, CHK2, WEE1, RAD51 and RAD52, represents a promising therapeutic strategy in cancer treatment.